CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 7 No. 5
 

Increased Folate Level Appears to Lower Colon Cancer Risk

May 1, 1998

BETHESDA, Md--When it comes to avoiding colon cancer, Grandma was right: Eat your vegetables, take vitamins, and forget that burger, for goodness sakes. Edward Giovannucci, MD, conveyed this basic message at a workshop on preventing colon cancer, held in conjunction with the American Society of Preventive Oncology (ASPO) annual meeting.

Dietary factors--red meat, fiber, and folate--are under increasing scrutiny for their effects on the development of colon cancer, said Dr. Giovannucci, assistant professor of medicine, Harvard Medical School. "Daily red meat consumption is associated with increased risk of colon cancer," he said, "while fiber intake and folate levels are inversely associated."

Essential in Remethylation

Numerous studies suggest that increased blood levels of folate may cut the risk of colorectal cancer, he said. Folate (or folic acid(Drug information on folic acid)) is essential in remethylation processes involving 5-methyl tetrahydro-folate and 5,10 methylene tetrahydrofo-late (5,10 MTHF). Both substances are needed by cells, and low levels of 5,10 MTHF may lead to DNA hypomethyl-ation, which could be carcinogenic in a variety of ways, possibly by increasing spontaneous mutations.

Another hint in this direction is that people with specific polymorphisms in the methyltetrahydrofolate reductase (MTHFR) gene have shown a higher colon cancer risk.

Two other dietary factors--alcohol and methionine--may complicate the action of folate in the body. Alcohol(Drug information on alcohol) can cut serum folate levels "dramatically" in a matter of days, Dr. Giovannucci said. People at highest risk are those with high alcohol intake and low folate or low methionine levels. Two drinks a day will raise the risk by 50%, and a heavy drinker with a poor diet will have an even greater risk, he said.

Methionine represents a contradiction. On the one hand, it is a constituent of red meat. On the other, it appears to be protective against colon cancer. He said that chicken and fish, which are also good sources of methionine, seem protective, while red meat is not.

Folate is no magic bullet, he said. The substance appears to exert its protective effects over time. Citing unpublished studies of multivitamin use (a marker for folate intake), he said that 1 to 4 years of taking vitamins did not reduce colon cancer risk at all; 5 to 14 years cut the relative risk to 0.8; and only after 15 or more years was risk reduced to 0.2. This suggests that folate may have some early role in carcinogenesis.

Folate does prevent colon cancer, he said, but at very high levels it also seems to promote tumor growth once cancer is present. But one would need a much higher intake of folate than 200 µg/day to influence tumor growth. Some treatments for colon cancer, he added, are designed to interfere with the folate cascade. "We might look at people with higher folate intake to see if they are diagnosed at a later stage or have lower survival rates."

Folate has other positive effects as well. It prevents neural tube defects in growing fetuses and may have a role in blocking heart disease by cutting homocysteine levels in the blood. Its only possible drawback, some have suggested, is that higher folate levels would mask vitamin B12 deficiency. "But that’s more theoretical than real," Dr. Giovannucci said. "There’s no epidemic of pernicious anemia in this country."

How can we increase the folate intake in the population? he asked. Because of the differences in folate availability in different foods, and individual differences in absorption, simply boosting dietary consumption is not enough. Dr. Giovannucci recommends a combination of increasing consumption of fruits and vegetables, fortification of foods, and use of vitamin supplements.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy